Barbi, et al. reported that although PIK3CA-mutant tumors were mostly in advanced T-stage, other characteristics of tumor aggressiveness were not significantly different according to PIK3CA mutation status [12]. The gene discussed is PIK3CA; the disease is neoplasm.